Search research articles
Contact Us
Filters
Showing results (71-80 of 191) with videos related to
Page
of 20
Sort By:
Journal of Clinical Lipidology
|
March 6, 2012
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism
Stefano Giannini, Gianluca Bardini, Ilaria Dicembrini, et al.
Journal of the American Podiatric Medical Association
|
January 19, 2011
Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patients
Matteo Monami, Maria Vivarelli, Carla Maria Desideri, et al.
Endocrine
|
April 3, 2020
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
Giovanni Antonio Silverii, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Care
|
February 7, 2009
Pulse pressure and prediction of incident foot ulcers in type 2 diabetes
Matteo Monami, Maria Vivarelli, Carla Maria Desideri, et al.
Journal of the American Podiatric Medical Association
|
March 19, 2008
The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms
Matteo Monami, Rosella Longo, Carla Maria Desideri, et al.
Acta Diabetologica
|
September 20, 2017
Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
Ilaria Dicembrini, Besmir Nreu, Alessia Scatena, et al.
Acta Diabetologica
|
October 26, 2013
GLP-1 receptor agonist-induced polyarthritis: a case report
Maria Luisa Ambrosio, Matteo Monami, Lavinia Sati, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 23, 2021
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials
Edoardo Mannucci, Lara Naletto, Gabriele Vaccaro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
August 8, 2021
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials
Edoardo Mannucci, Besmir Nreu, Chiara Montereggi, et al.
Diabetes, Obesity & Metabolism
|
March 1, 2017
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
Matteo Monami, Besmir Nreu, Alessia Scatena, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 191) with videos related to
Sort By:
Page
of 20
Journal of Clinical Lipidology
|
March 6, 2012
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism
Stefano Giannini, Gianluca Bardini, Ilaria Dicembrini, et al.
Journal of the American Podiatric Medical Association
|
January 19, 2011
Autologous skin fibroblast and keratinocyte grafts in the treatment of chronic foot ulcers in aging type 2 diabetic patients
Matteo Monami, Maria Vivarelli, Carla Maria Desideri, et al.
Endocrine
|
April 3, 2020
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
Giovanni Antonio Silverii, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Care
|
February 7, 2009
Pulse pressure and prediction of incident foot ulcers in type 2 diabetes
Matteo Monami, Maria Vivarelli, Carla Maria Desideri, et al.
Journal of the American Podiatric Medical Association
|
March 19, 2008
The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms
Matteo Monami, Rosella Longo, Carla Maria Desideri, et al.
Acta Diabetologica
|
September 20, 2017
Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
Ilaria Dicembrini, Besmir Nreu, Alessia Scatena, et al.
Acta Diabetologica
|
October 26, 2013
GLP-1 receptor agonist-induced polyarthritis: a case report
Maria Luisa Ambrosio, Matteo Monami, Lavinia Sati, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 23, 2021
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials
Edoardo Mannucci, Lara Naletto, Gabriele Vaccaro, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
August 8, 2021
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials
Edoardo Mannucci, Besmir Nreu, Chiara Montereggi, et al.
Diabetes, Obesity & Metabolism
|
March 1, 2017
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
Matteo Monami, Besmir Nreu, Alessia Scatena, et al.
Page
of 20